Literature DB >> 9665429

Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects.

J J Pitt1, S Hauser.   

Abstract

We describe biochemical and clinical features of 11 subjects (ages, 1.2-84 years, nine females and two males) with transient 5-oxoprolinuria (0.6-23.6 mol/mol of creatinine, reference range <0.07). A variety of conditions preceded the onset of acidosis, and all had taken acetaminophen (paracetamol), although in therapeutic amounts in most subjects. Metabolic acidosis was documented in nine subjects, and all had an increased anion gap and abnormal liver functions. 5-Oxoproline was the major urinary organic acid in five subjects, whereas the rest had more complex profiles comprising 5-oxoproline and other organic acids, such as lactate, 3-hydroxybutyrate, and 4-hydroxyphenyl lactate. The 5-oxoproline was predominantly of the L-configuration. One subject died during an acidotic episode, and the rest recovered with no apparent long-term ill effects. Urinary 5-oxoproline was within the reference range in six subjects that were re-tested after the anion gap normalized. These findings suggest that acetaminophen, in association with other unidentified factors, is involved in the development of this condition through a mechanism of depletion of liver glutathione stores.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665429

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  18 in total

1.  5-Oxoprolinuria as a cause of high anion gap metabolic acidosis.

Authors:  Rajanshu Verma; Karthik R Polsani; Jeffrey Wilt; Mark E Loehrke
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

2.  Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: an under diagnosed phenomenon.

Authors:  L Morgan Nordstrom O'Brien; Michael Hooper; Mark Flemmer; Paul Ellis Marik
Journal:  BMJ Case Rep       Date:  2012-07-03

3.  Severe hyperhomocysteinaemia and 5-oxoprolinuria secondary to antiproliferative and antimicrobial drug treatment.

Authors:  B Schwahn; G Kameda; R Wessalowski; E Mayatepek
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  New insights into the genetics of 5-oxoprolinase deficiency and further evidence that it is a benign biochemical condition.

Authors:  Eduardo Calpena; Anup Arunrao Deshpande; Sufin Yap; Akhilesh Kumar; Nigel J Manning; Anand K Bachhawat; Carmen Espinós
Journal:  Eur J Pediatr       Date:  2014-08-17       Impact factor: 3.183

5.  Metabolic Acidosis in a Pediatric Patient with Leukemia and Fungal Infection.

Authors:  Keito Hoshitsuki; Alejandro R Molinelli; Hiroto Inaba; Jeffrey E Rubnitz; Patricia J Barker
Journal:  Clin Chem       Date:  2020-04-01       Impact factor: 8.327

Review 6.  Pharmacologically-induced metabolic acidosis: a review.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

7.  Understanding lactic acidosis in paracetamol (acetaminophen) poisoning.

Authors:  Anoop D Shah; David M Wood; Paul I Dargan
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

8.  Unexplained metabolic acidosis in critically ill patients: the role of pyroglutamic acid.

Authors:  Barry A Mizock; Stanislav Belyaev; Carter Mecher
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

Review 9.  Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle.

Authors:  Michael Emmett
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

10.  Profound metabolic acidosis and oxoprolinuria in an adult.

Authors:  Michael J Hodgman; James F Horn; Christine M Stork; Jeanna M Marraffa; Michael G Holland; Richard Cantor; Patti M Carmel
Journal:  J Med Toxicol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.